Abstract
The development of thermostable vaccines can relieve the bottleneck of existing vaccines caused by thermal instability and subsequent poor efficacy, which is one of the predominant reasons for the millions of deaths caused by vaccine-preventable diseases. Research into the mechanism of viral thermostability may provide strategies for developing thermostable vaccines. Using Newcastle disease virus (NDV) as model, we identified the negative surface charge of attachment glycoprotein as a novel determinant of viral thermostability. It prevented the temperature-induced aggregation of glycoprotein and subsequent detachment from virion surface. Then structural stability of virion surface was improved and virus could bind to and infect cells efficiently after heat-treatment. Employing the approach of surface charge engineering, thermal stability of NDV and influenza A virus (IAV) vaccines was successfully improved. The increase in the level of vaccine thermal stability was determined by the value-added in the negative surface charge of the attachment glycoprotein. The engineered live and inactivated vaccines could be used efficiently after storage at 37°C for at least 10 and 60 days, respectively. Thus, our results revealed a novel surface-charge-mediated link between HN protein and NDV thermostability, which could be used to design thermal stable NDV and IAV vaccines rationally.
Author summary
The development of thermal stable vaccines can assist in the execution and expansion of global immunization programs, due to their decreased dependence on the cold chain for transport and storage. Research into the mechanism of viral thermostability may provide strategies for developing thermal stable vaccines. However, the mechanism by which an enveloped virus inherits its thermostability is poorly understood. Previously, we identified that the attachment glycoprotein (hemagglutinin-neuraminidase, HN) was responsible for the thermostability of Newcastle disease virus (NDV). In the present study, we further demonstrated that negative surface charge of HN protein positively regulated the thermostability of NDV through preventing the aggregation of HN protein. By genetically engineering charge-associated amino acid mutations onto the surface of the attachment glycoprotein of an enveloped virus vaccine strain, we remarkably improved the NDV and influenza virus vaccine’s thermal stability and potency. Based on these data, we proposed a novel surface-charge-mediated link between HN protein and NDV thermostability, and provided a novel strategy for rational design of thermal stable enveloped virus vaccines.
Introduction
Enveloped viruses encased by a host-derived lipid layer, such as serve acute respiratory syndrome coronavirus 2, Zika virus, influenza A virus (IAV), and Newcastle disease virus (NDV), which significantly affect the health of humans and animals, also pose a considerable threat to the global economy [1–4]. The effective prevention and control of infectious diseases usually depends on worldwide vaccination strategies. For example, vaccines against measles, mumps, and influenza, have been used to immunize billions of people. However, more than 17 million people still die from infectious diseases [5]. Many of these diseases are vaccine-preventable, and deaths are therefore caused by the underuse of vaccines. One of the predominant reasons for this is that the majority of existing vaccines are sensitive to heat, and a cold chain is therefore required to maintain the quality of vaccines during transport and storage. This creates a huge burden in developing countries in terms of cost and logistics, with the cold chain constituting up to 80% of the total cost of vaccination programs [6]. Moreover, the cold chain is not always reliable for reasons such as human errors, inappropriate cold chain equipment, and power shortages [7–9]. This may lead to the rapid loss of vaccine potency and inadequate protection against disease. The situation is particularly challenging in developing and less-developed countries. It is estimated that ~50% of vaccines are discarded annually, and poor thermal stability is the main contributing factor in this wastage [10]. Therefore, improving the thermal stability of vaccines to ensure that they are partially or completely independent of the cold chain is of great importance.
New methods have been proposed that may be used to improve the thermal stability of vaccines. Firstly, thermostable formulations of vaccines were produced by optimizing the properties of the solvent (e.g., buffer, pH, and salt concentration), and by adding stabilized excipients (e.g., sucrose, serum albumin, and nonionic surfactants) [11,12]. For example, the thermostable rotavirus vaccine, licensed in India, can be stored at a temperature below 25°C for 36 months. Secondly, by integrating the biomimetic nucleating peptides onto the capsid protein of enterovirus type 71 vaccine strain, calcium phosphate mineralization was induced on viral surfaces under physiological conditions, generating a mineral exterior. This self-biomineralized vaccine could be stored at 37°C for 1 week [13]. Thirdly, structural vaccinology could guide the design of effective vaccines through stabilizing their native conformations [14–16]. By introducing cysteine residues and filling hydrophobic cavities, the engineered pre-fusion F protein of respiratory syncytial virus showed improved thermostability and superior immunogenicity when compared to the post-fusion F protein [17]. Finally, although most of the existing vaccine strains are sensitive to heat, a few are thermostable, such as NDV V4 and TS09-C strains [18,19]. After incubation at 27°C– 32°C for 14 days, the viral titer of freeze-dried V4 vaccine only reduced from 1010.4 to 109.3 EID50 per vial [20]. It has been demonstrated that the thermostability of NDV was dependent on the origin of hemagglutinin-neuraminidase (HN) protein using reverse genetic technology. A recombinant thermostable NDV strain rLS-T-HN, encoding the TS09-C HN protein in the thermolabile LaSota backbone, could still induce a protective antibody response after storage at 30°C for 16 days [21].
NDV belongs to the Avulavirus genus in the family Paramyxoviridae, and encodes six structural proteins. Viral particles contain two surface glycoproteins embedded in a lipid membrane, fusion (F) protein and HN protein [22]. The HN protein is a type II integral membrane protein consisting of an N-terminal transmembrane domain (TM), a stalk region, and a C-terminal global head region. The HN is presented as a homo-tetramer with disulfide-linked dimers [23,24]. HN is a multifunctional protein involved in the recognition of sialic acid-containing receptors on the cell surface, the removal from receptors, and the interaction with F protein to promote fusion.
All proteins have surface electrostatic properties, which are strongly related to the pH of the solution and the isoelectric point (pI) of the protein itself. If the pH of the solution is equal to the protein pI, the surface charge of the protein is zero. As an intrinsic property of protein, the pI depends mostly on the dissociation constants for the ionizable groups of seven charged amino acids. Among them, Asp, Glu, Tyr, and Cys are negatively charged amino acids (NC-A), while His, Lys, and Arg are positively charged amino acids (PC-A) [25]. The surface charges are involved in a wide range of biochemical processes within the proteins, e.g., folding, binding to different targets (other proteins, nucleic acids, and the cell membrane), subcellular localization (cytoplasm, nucleus, and the cell membrane), and condensation [26]. Within the virus particles, the surface charges play an important role in various sorption processes. For example, the determination of the virus concentration from a large volume of water is achieved by adsorption to charged microporous filters [27]. The virus can be purified by chrome-focusing based on its surface charge [28].
Although the thermostability of enveloped viruses has been studied extensively [18,19,29–33], the mechanism for viral thermostability is poorly understood. In this study, using the thermostable and thermolabile NDV vaccine strains as a model, we reported a novel mechanism for the thermostability of enveloped virus. The negative surface charge of attachment glycoprotein positively regulated viral thermostability through preventing the aggregation of glycoproteins. The surface charge engineering method was thereby developed to improve the thermal stability of NDV and IAV vaccines. The surface-charge-engineered vaccines exhibited overall improved thermal stability and maintained protective efficacy even after storage at 37°C for at least 10 days.
Materials and methods
Ethics statement
Animal experiments were approved (Permit number: 28/2020) and supervised by the Institutional Animal Care and Use Committee of the Hubei Academy of Agricultural Sciences.
Cells and viruses
The BHK-21 and MDCK cells were cultured in Dulbecco’s modified Eagle medium (DMEM) with 10% fetal bovine serum (FBS). The fourteen NDV strains (Ulster, TS09-C, V4, I-2, W4, D4, F48E8, 39, LaSota, Mukteswar, HN1107, HB1103, HB0901 and HB0601) and H1N1 subtype IAV strain PR8-E were maintained at Hubei Academy of Agricultural Sciences.
Calculation of protein charges
The Isoelectric Point Calculator (IPC), a freely available, web service program (http://isoeletric.org), was used to calculate the theoretical charges of proteins at pH 7.4, based on their amino acid sequences. The 26,827 full-length sequences of attachment glycoproteins from 10 enveloped viruses were obtained from the NCBI GenBank database.
Virus titration
The titers of viruses were determined by the HA assay in 96-well micro-plates using 0.5% chicken red blood cells, the 50% egg infectious dose (EID50) assay in 10-day-old SPF chicken embryos, the 50% tissue culture infectious dose (TCID50) assay for NDV in BHK-21 cells in the presence of 0.2 μg/ml TPCK-trypsin, and TCID50 assay for IAV in MDCK cells (1.0 μg/ml TPCK-trypsin) [34].
Infectivity thermostability test
Aliquots of undiluted allantoic fluids infected with viruses were sealed in air-tight vials at 0.1 ml/vial and submerged into a water bath at 56°C for varying time points. The heat treatment was stopped by transferring the vials into an ice-cold bath. The infectivity of the virus in the vials was titrated by a TCID50 assay. The decreased infectivity of viruses was represented on a logarithmic scale as a function of the heat treatment time. Regression lines were plotted from four time points. Viral thermostability was shown as the mean time for a 1 log10 (90%) infectivity decrease (T90).
Construction and rescue of mutated or chimeric viruses
For NDV mutants, the mutated infectious cDNA clones (ICs) were constructed by replacing the wild-type HN gene fragment in the backbone of the ICs with the corresponding mutated HN gene, as described previously [21]. In brief, the vector fragment was PCR amplified using the backbone of the ICs as a template and vector-specific primers to exclude the HN gene fragment (6412–8262 nt). The mutated HN gene (6412–8262 nt) was constructed by multiple overlapping PCR amplifications, using the backbone of the ICs as a template and specific primers containing the corresponding mutations. Subsequently, chimeric ICs were generated by ligation of the two PCR products, i.e., the mutated HN gene and the vector fragment. Rescue of the chimeric viruses was performed by co-transfecting the mutated ICs, and the NP, P, and L supporting plasmids into BHK-21 cells pre-infected with MAV-T7. The cell lysates were collected by freeze/thawing for three times at 72 h post-transfection, passed through a 0.20-μm-pore-size filter, and inoculated directly into the allantoic cavities of 10-day-old specific-pathogen-free (SPF) chicken embryos without dilution [35].
Similarly, the chimeric NDV rTS-L-HN/A, rTS-L-HN/B and rTS-L-HN/C were constructed by replacing the HN fragments 1–126, 127–370, 371–577 aa, respectively, in ICs of TS09-C, with the counterpart fragments from LaSota strain. The chimeric NDV rLS-T-HN/A, rLS-T-HN/B, and rLS-T-HN/C were constructed by replacing the HN fragments 1–126, 127–370, 371–561 aa, respectively, in ICs of LaSota, with the counterpart fragments from TS09-C strain.
For IAV mutants, all eight gene segments of the egg-adapted H1N1 influenza virus strain A/PR/8/34 (PR8-E) were cloned into the pHW2000 vector to generate recombinant viruses as described previously [36]. The construction of mutated pHW-HA was similar to that of chimeric NDV ICs. The rescue of chimeric IAVs was performed as described previously [36].
All of the rescued viruses were amplified in 10-day-old SPF chicken embryos and confirmed by a hemagglutination (HA) assay using 0.5% chicken red blood cells and DNA sequencing.
Molecular modeling of protein structures
The structures of the attachment glycoproteins from the wild-type and mutated viruses used in this study were obtained by homology modeling using the SWISS-MODEL web server [37]. For NDV HN protein, the templates used for homology modeling were the HN structures of AV strain (PDB ID code 3T1E), Ulster strain (4FZH), and Kansas strain (1USR). For IAV HA protein, the template was the HA structure from P1/1951 strain (6N41). The protein structures were visualized using the PyMOL program (The PyMOL Molecular Graphics System, Version 1.1eval, Schrodinger, LLC). The electrostatic surface potentials and iso-potential contours of proteins were calculated and displayed using PDB2PQR and the APBS-tool of PyMOL [38].
Virus pathogenicity assays
The pathogenicity of NDV in birds was determined by using the intracerebral pathogenicity index (ICPI) assay in 1-day-old SPF chickens and the mean death time (MDT) assay in 10-day-old SPF embryonated eggs [34].
The pathogenicity of IAV in mice was determined by inoculating the virus into six-week-old female BALB/c mice (anesthetized with ether) with a dose of 103.0 EID50 via the intranasal route. Weight loss and survival of infected mice were monitored daily for 14 days. Mice that lost > 20% of the original body weight were humanly euthanized and documented as dead.
Neuraminidase (NA) activity test
NA activity was tested using the NA assay kit (Beyotime, China). According to the manufacture instructions, 50 ng of HN protein or 10 μl of allantoic fluids infected with NDV was mixed with 70 μl of detection buffer, 10 μl of fluorogenic substrate and 10 μl of water. Then the mixture was incubated at 37°C for 30 min, followed by detecting the NA fluorogenic substrate cleaved by virus or protein, using a Fluorescence Spectrophotometer (Hitachi, F-7000) with an excitation wavelength of 322 nm and an emission wavelength of 450 nm. NA activity was represented as fluorescence intensity of samples above that of corresponding solutions without virus or protein.
NDV R18 labeling and binding assay
NDV labeled with R18 was prepared as described previously [39]. Briefly, 500 μl of Hanks’s balanced salt solution (HBSS) containing the purified virus (250 μg) was mixed with 12 μl of R18 (3 μg), and incubated at room temperature for 1 hour. The unincorporated R18 was removed by filtration through a 0.22 μm syringe filter (Millipore). Finally, 500 μl of labeled virus was obtained and used freshly for the binding assay.
R18-labeled NDV were heat-treated at 56°C for 10 min, then inoculated into BHK-21 cells (moi 50) at 37°C for 30 min. Then cells were washed three times with PBS, and cultured with a complete medium. At 1 hour post infection (hpi), the cells were observed directly for the red signal of R18 by using fluorescence microscopy. At 7 hpi, the cells were fixed with 4% paraformaldehyde, stained with anti-HN rabbit antibody (prepared by our laboratory) followed by the FITC-conjugated secondary antibody (Clontech) staining, and examined for the green signal of FITC by using fluorescence microscopy.
Western blot based NDV binding assay
Pelleted BHK-21 cells were prepared by detaching the adherent cells with versine solution and washing twice with PBS, then chilled on ice. The allantoic fluids infected with NDV were heat-treated at 56°C, then transferred to an ice-bath at the indicated time points. The heat-treated virus was divided into two portions. One was incubated with the pelleted cells (moi 10) at 4°C, and the other was kept for further western blot analysis as virus input. After incubated for 1 hour, the cells were precipitated by centrifugation, washed twice with PBS, and resuspended in DMEM of equal volume to the incubated virus. The resuspended cells binding with NDV and an equal volume of virus input were resolved by SDS-PAGE and subjected to western blot with rabbit serum against HN protein.
Protein isolation and purification
The HN protein cleaved from viral particles of NDV was prepared as described previously [40]. NDV propagated in 10-day-old SPF chicken embryos, was purified by sucrose density gradient centrifugation. To isolate membrane proteins, the purified NDV was treated with 1% Triton X-100, and ultra-centrifugated at 100,000 g for 2 h at 4°C, then the supernatant containing membrane proteins was collected. To remove Triton X-100, the supernatant was incubated with Bio-Beads SM-2 Adsorbent (Bio-Rad), resulting in the reconstitution of virosomes containing membrane proteins. To cleave HN proteins, the virosomes were incubated with chymotrypsin (0.5 mg/ml) overnight at room temperature. The chymotrypsin digestion was terminated by adding TPCK (60 μg/ml). The cleaved HN protein was separated from virosomes by ultra-centrifugation at 100,000 rpm for 2 h at 4°C, and further concentrated by filtration through Centrifugal Filters Ultracel-50K (Millipore). The purified HN protein was analyzed by SDS-PAGE and stored at -80°C.
Protein NA stability assay
Aliquots of purified HN protein (5.0 μg/ml) diluted with HBSS, were sealed in air-tight vials at 0.1 ml/vial. The vials were submerged into a water bath at the indicated temperature for 10 min, then transferred to an ice-cold water. The NA activities of heat-treated proteins in vials were determined by using the NA assay kit. The decreased NA activities of HN proteins were shown on a percent scale as a function of heat-treatment temperature. The protein stability of HN was shown as the temperature for a 50% decrease in NA activity of the protein heat-treated for 10 min (Tm-NA).
TEM images
Morphological observation of heat-treated virion (0.1 mg/ml) and purified HN (0.1 mg/ml) was carried out after negatively staining with phosphotungstic acid and uranyl formate, respectively, using a Tecani G20 microscope (FEI).
Zeta potential and size measurement
For virion and purified HN proteins, the Zeta potentials and sizes were measured using a Zetasizer Nano ZS apparatus (Malvern). Samples were prepared at a concentration of 0.1 mg/ml in 10mM Tris-HCl (pH 5.5, 7.4 and 8.0) containing 20 mM NaCl. Measurements were carried out at 25°C.
Circular dichroism (cd)
CD experiments were carried out on a CD spectropolarimeter by Applied Photophysics. Far-UV CD spectra were acquired in triplicate at 25°C in a 1 mm quartz cylindrical at a HN protein concentration of 0.1 mg/ml. Temperature-induced transition of HN protein was monitored by recording ellipticity at 222 nm as a function of temperature in 50 mM PBS (pH 7.5). Secondary structure estimation was calculated using Circular Dichroism analysis using Neural Networks (CDNN).
Vaccine preparation and animal experiments
The live liquid vaccines were prepared by diluting the allantoic fluids infected with recombinant (r)NDVs to a final viral concentration of 107.0 EID50/ml with Tris-HCl (pH 7.8) containing 3% gelatin. Groups of 2-week-old SPF chickens were immunized with fresh or stored live NDV vaccines at a volume of 0.1 ml via the intranasal and intraocular (in/io) routes, and were then challenged with a lethal dose of NDV strain F48E8 at 2 weeks post-vaccination. The challenged birds were monitored daily over a 2-week period for clinical signs and mortality. Sera were collected prior to the challenge and were detected for NDV antibody using a hemagglutinin inhibition (HI) assay.
The inactivated vaccines were prepared by inactivating the allantoic fluids infected with rNDVs or rIAVs using 0.05% Beta-Propiolactone (BPL) at 37°C for 2 h, followed by diluting to 107.5 EID50/ml with Tris-HCl (pH 7.8). BALB/c mice and SPF chickens were used to evaluate the IAV and NDV vaccines, respectively. Groups of animals were immunized with the fresh or stored vaccines at a volume of 0.5 ml via the intramuscular (im) route, and were challenged with a lethal dose of NDV strain F48E8 or IAV strain rPR8-E at 4 weeks post-vaccination. The antibody responses prior to the challenge and protection rates were determined.
Results
Positive correlation between the negative surface charge of HN protein and the thermostability of NDV
To explore the mechanism for thermostability of enveloped viruses, we previously reported that the major protein that determined viral thermostability was the attachment glycoprotein, by using thermostable and thermolabile NDV strains as models [21]. Here, we narrowed down the crucial region in HN where the thermostable determinant resided. The HN gene was divided into 3 fragments (A, B, and C). Six chimeric NDVs were constructed by the exchange of HN fragments between TS09-C and LaSota strain, and their thermostability was assessed (Fig 1A). All the three chimeric viruses on the background of TS09-C exhibited the greatly decreased thermostability, compared with the rTS09-C virus. However, their thermostability was still much higher than that of rTS-L-HN, which was constructed by replacing the complete HN gene in TS09-C with that of LaSota. Similar results were obtained from the chimeric viruses on the background of LaSota strain. Results suggested that a combination of amino acids located at several regions in the HN protein determined the viral thermostability.
By comparison the HN protein sequences from four thermostable and four thermolabile NDV strains, a total of 112 amino acid substitutions was found (S1 Fig). Interestingly, when comparing the contents of amino acids with different character (including negatively charged, positively charged, uncharged polar and hydrophobic) in HN protein between thermostable and thermolabile NDV strains, only the content of negatively charged amino acids was found to be significantly different between thermostable and thermolabile NDV strains (Fig 1B). Among the negatively charged amino acids, the contents of Asp and Glu in HN from thermostable viruses were significantly higher than those from thermolabile viruses (Fig 1C). Using Isoelectric Point Calculator (IPC), the theoretical charges of the HN proteins at pH 7.4 were calculated and compared between thermostable and thermolabile viruses. All the HN proteins are negatively charged, and the average negative charge of HN from thermostable viruses was 2.8-fold higher than that from thermolabile viruses (p < 0.001) (Fig 1D). The thermostability of NDV isolates was proportional to the increasing negative charge of HN protein up to -13, at which the Ulster strain exhibited a maximum viral thermostability (Fig 1E). This phenomenon indicated a positive correlation between the negative charge of HN protein and NDV thermostability.
To characterize the amino acid substitutions that may affect the charge of HN protein, we compared the HN protein sequences from four thermostable and four thermolabile NDV strains and found a total of 45 charged amino acid substitutions (S1 Fig). The influence of each charged amino acid substitution on the HN charge of TS09-C strain was analyzed, and there were 29 amino acid substitutions that considerably changed the charge (charge-associated amino acids) of HN protein (Δ Ch ˃ 0.04 and Δ Ch < ˗0.04) (Fig 1F). By homology modeling using the HN structure of AV strain (PBD ID code 3T1E, from 124 to 615 aa) as a template, the HN structures of several NDV strains were obtained and analyzed. There were 23 charge-associated amino acid substitutions located in the region of 124–615 aa, and all of them were situated on the surface of the HN homo-tetramer (Fig 1G). The electrostatic potentials on the surface of HN proteins from thermostable and thermolabile viruses were analyzed and compared. NDV bearing HN with a higher negative surface charge, exhibited higher thermostability (Fig 1H–1J). Similar results were observed by homology-modeling of these HN structures using the HN structures of strains Ulster (PBD ID code 4FZH) and Kansas (PBD ID code 1USR) as a template (S2 Fig). These data suggested that the thermostability of NDV positively correlates with the negative surface charge of HN protein.
Negative surface charge of HN protein is the crucial thermostable determinant of NDV
To confirm the positive correlation between viral thermostability and the negative surface charge of the HN protein, we generated a series of NDV TS09-C mutants bearing HN proteins with different charges (Fig 2A), by introducing charge-associated amino acid substitutions obtained by comparing the HN proteins sequences (S1 Fig). Then the thermostability of NDV mutants was determined. As shown in Fig 2B, the thermostability of these NDV mutants was proportional to the decreasing negative charge of their HN proteins down to ˗0.1, at which rTS-HN-P11 had the lowest viral thermostability. NDV mutant rTS-HN-N3, with an increased negative charge of HN (Δ Ch = ˗4.0) exhibited an improved thermostability (183%, 23.3/12.7). These results confirmed that the negative charge of HN protein positively regulated the thermostability of NDV.
There are four types of basic charge-associated amino acid substitutions, including uncharged amino acid (UC-A) to NC-A, NC-A to UC-A, PC-A to UC-A, and UC-A to PC-A. To evaluate the individual effect of different types of charge-associated amino acid substitutions on viral thermostability, we generated four NDV mutants, rTS-HN-UN4, rTS-HN-PU4, rTS-HN-UP4, and rTS-HN-NU4, containing one of the four types of charge-associated amino acid mutations, respectively (Fig 2A). The viral thermostabilities of rTS-HN-UN4 and rTS-HN-PU4 bearing HN proteins with increased negative charges were higher than that of the parental TS09-C strain, while those of the other two viruses were lower than that of TS09-C (Fig 2B). Therefore, all four types of basic charge-associated amino acid substitutions in the HN protein could individually affect viral thermostability.
By comparing the electrostatic potentials colored on the molecular surfaces of the mutated HN proteins and their corresponding viral thermostability, it was also concluded that the negative surface charge of HN protein was positively correlated with the thermostability of NDV (Fig 2C). All of the NDV mutants showed similar growth titers and pathogenicity compared with their parental viruses (S1 Table). The thermostability of NDV mutants was not remarkedly changed after serial passage in chicken embryos (S3 Fig) and the revertant virus was not detected by RT-PCR sequencing assay. Taken together, our results demonstrated that the thermostability of NDV could be positively regulated by the negative surface charge of HN protein, through the method of introducing charge-associated amino acid mutations.
Effect of negative surface charge of HN on the cell-binding stability of NDV
The main function of attachment protein is to recognize and bind to the receptors exposed on target host cells. To explore the mechanism by which the negative surface charge of attachment protein mediates viral thermostability, we evaluated the stability of the cell-binding activity of NDV mutants and their subsequent effect on viral replication in cells.
The NDV HN protein possesses HA and NA activities. Two NDV mutants, rTS-HN-N3 and rTS-HN-P4, sharing the same TS09-C backbone and representing thermostable and thermolabile strains, respectively, were examined in vitro for the stabilities of viral HA and NA activity. Fig 3A shows that the HA stabilities of these NDV mutants differed greatly, in the order of rTS-HN-N3 ˃ rTS09-C ˃ rTS-HN-P4. Similar results were obtained from the NA stability test (Fig 3B). These results indicated that the negative surface charge of HN protein positively regulated the HA and NA stabilities of the virus.
Morphological changes in heat-treated rNDVs were examined by transmission electron microscopy. As shown in Fig 3C, an obvious morphological difference between the heat-treated rTS-HN-N3 and rTS-HN-P4 was observed on the surface of viral particles. For rTS-HN-P4, the surface glycoproteins were completely detached from the viral envelope after heat-treatment, and only naked viral particles were observed. In contrast, the surface glycoproteins were evenly distributed on the envelope of heat-treated rTS-HN-N3. The viral particles of both rTS-HN-N3 and rTS-HN-P4 were neither aggregated nor broken by heat-treatment at 56°C. The heat-treated viruses did not display an obvious change in particle sizes compared with the untreated viruses (S4 Fig). These findings suggested that the negative surface charge of HN affected the structural stability of the virion surface.
To evaluate the cell-binding ability of heat-treated rNDVs, NDV rTS-HN-N3 and rTS-HN-P4 were labeled with the lipophilic fluorescent dye R18, producing R18-NDVs. After heat-treatment at 56°C for 10 min, the R18-NDVs were inoculated into BHK-21 cells at 37°C for 7 h, then the HN protein was detected using an indirect immunofluorescence assay. As shown in Fig 3D, at 1 h post-infection, the R18 red signal was not observed in cells infected with heat-treated rTS-HN-P4 virus. In contrast, the cells infected with heat-treated rTS-HN-N3 displayed strong red signals. Similar results were observed from the detection of HN expression in BHK-21 cells by performing an immunofluorescence assay at 7 h post-infection (Fig 3D). The cell-binding efficiency of the heat-treated virus was further evaluated by performing an immunoblot assay. After heat-treatment for 10 min, cell-binding NP protein was more abundant in rTS-HN-N3 than in rTS-HN-P4 (Fig 3E). Regarding the replication levels of the genomic RNA and infectious virus, the heat-treated rTS-HN-N3 showed slightly lower levels than the untreated virus, but these were still substantially higher than the heat-treated rTS-HN-P4 (Fig 3F and 3G). Therefore, the negative surface charge of HN affected viral thermostability mainly through regulating the cell-binding stability of the virus.
Effect of a negative surface charge on the temperature-induced aggregation of HN protein
To further explore the mechanism by which the negative surface charge of HN mediates the cell-binding stability of NDV, two mutated HN proteins were isolated by cleaving HN (cHN) from the viral particles of NDV rTS-HN-N3 and rTS-HN-P4 with chymotrypsin, named cHN-N3 and cHN-P4, respectively (Figs 4A and S5). The protein stability of these cHNs was characterized in vitro by performing an NA stability assay. Fig 4B shows that the temperature required to achieve a 50% decrease in NA activity (Tm-NA) of cHN-N3 was considerably higher than that of cHN-P4. The Tm-NA difference between these two proteins was approximately 5.5°C, which was consistent with the difference between their corresponding NDV mutants. These results demonstrated that the negative surface charge of HN could also improve the stability of the protein itself.
The structural stability of the cHN proteins was further estimated following temperature-induced transition using CD spectroscopy. We analyzed the CD spectra of cHN-N3 and cHN-P4 at various temperatures ranging from 40°C to 75°C with 5°C intervals (Fig 4C and 4D). The ellipticities at 222 nm for the two proteins were plotted against temperature, and their melting temperatures Tm-CD were determined (Fig 4E). The Tm-CD of cHN-N3 and cHN-P4 were estimated to be 54.1°C and 60.8°C, respectively, similar to the Tm-NA values of these two proteins (54.5°C and 60.0°C). The secondary structure contents of cHN proteins at several temperatures ranging from 40 and 75°C, were computed based on the CD spectra using CDNN. When the temperature rose, the α-helix and β-sheet contents of cHN proteins were increased and decreased (Fig 4F and 4G), respectively. This computed outcome was contrary to the results obtained from typical proteins, such as BSA (S6 Fig). Overall data obtained from the HN structural stability study suggested that the negative surface charge affected the structural stability of HN protein itself.
The size of cHN proteins was measured using dynamic light scattering (DLS). Under normal conditions, cHN proteins are approximately 10 nm in size. After heat-treatment at 56°C for 10 min, the size of cHN-P4 was increased to approximately 40 nm, while that of cHN-N3 remained unchanged (Fig 5A). The sizes of the two proteins were plotted against temperature, and the temperature at which a 50% increase in protein size (Tm-SZ) was obtained was determined (Fig 5B). The Tm-SZ values for cHN-N3 and cHN-P4 were estimated to be 52.3°C and 58.2°C, respectively, slightly lower than the Tm-CD values of these two proteins. Morphological changes in heat-treated proteins were further examined by transmission electron microscopy. Unlike the untreated proteins, the cHN-P4 became aggregated after heat-treated at 56°C for 10 min, whereas cHN-N3 became aggregated only after the treatment at 60°C for 10 min (Fig 5C). These findings indicated that a negative surface charge affected the stability of HN protein through regulating temperature-induced aggregation.
The pH and ionic strength of a solution could also affect the surface charge of a protein. As shown in Figs 5D and S7, the stability of cHN proteins decreased with either decreasing pH or increasing ionic strength. The effects of both pH and ionic strength on protein stability were reversible (S8 Fig). The surface electrical charges (Zeta potentials) of the HN proteins were measured using a Zetasizer Nano ZS apparatus. As expected, the negative surface charge of cHN-N3 was increased as the pH rose, and remained consistently higher than that of cHN-P4 at the same pH (Fig 5E). The negative iso-potential contours were displayed on the surface of the cHN structures by homology modeling (Fig 5F–5H). Protein cHN-N3 displayed more marked negative iso-potential contours than those of cHN-TS and cHN-P4, in the order of cHN-N3 > cHN-TS > cHN-P4. The effect of negative surface charge on HN stability was summarized (Fig 5I). Taken together, we elucidated a mechanism for the thermostability of NDV. The highly negative surface charge of HN protein improved the structural stability of the virion surface through preventing the temperature-induced aggregation of HN and subsequent detachment from viral particles, thereby enabling the virus to efficiently bind to and infect cells after heat-treatment.
Improved thermal stability of NDV vaccines by increasing the negative surface charge of HN protein
Previously, the stability of NDV thermostable vaccine strain TS09-C was optimized successfully by surface charge engineering. Next, we tested whether the stability of a thermolabile NDV vaccine strain LaSota could be improved using the same method. Two NDV mutants rLS-HN-N5 and rLS-HN-N10 containing 5 and 10 charge-associated amino acid mutations in the HN protein, respectively, were constructed (Fig 6A) and tested for thermostability. Compared with the parental rLaSota strain, both NDV mutants displayed a greatly improved thermostability, in the order of rLS-HN-N10 > rLS-HN-N5 > rLaSota (Fig 6B), and retained the lentogenic pathotype and similar growth titers (S1 Table). Therefore, the thermal stability of the thermolabile LaSota strain could also be improved by surface charge engineering.
The loss of potency of rLS-HN-N10, as either a live or inactivated vaccine, during storage was evaluated. Firstly, the live liquid vaccine strains rLS-HN-N10 and rLaSota were stored at 37°C for varying time periods, and the subsequent infectivity was titrated by a TCID50 assay. Fig 6C shows that the T90 values of rLS-HN-N10 and rLaSota were 16.7 and 2.2 days, respectively. The infectivity inactivation rate of rLS-HN-N10 was 7.6-fold slower than that of rLaSota. Similar results were obtained for the live vaccines stored at 42°C (Fig 6D). The immunogenicity of the heat-treated live vaccines was then verified in animals. Live vaccines were incubated at 37°C for 5 and 10 days, and groups of birds were then immunized via the in/io routes. As shown in Fig 6E, before heat-treatment, the mean HI antibody titers in the rLS-HN-N10 and rLaSota groups were 7.2 and 5.7 log2, respectively. After storage for 5 days, the HI titers in the rLaSota group were considerably lower than 4.0 log2, and rLaSota vaccine could not completely protect birds against lethal challenge. However, rLS-HN-N10 vaccine could still provide complete protection after storage at 37°C for 10 days. Secondly, the inactivated vaccines rLS-HN-N10 and rLaSota were evaluated for potency loss at 37°C. The HA inactivation rate of rLS-HN-N10 was 4.4-fold slower than that of rLaSota (Fig 6F). Similar results were obtained for the inactivated vaccines stored at 42°C (Fig 6G). In animal experiments, after storage for 30 days, the inactivated vaccine rLaSota induced a low HI antibody response and provided only a 40% protection rate against lethal challenge. However, inactivated vaccine rLS-HN-N10 could still provide 100% protection after storage at 37°C for 60 days (Fig 6H). Collectively, these data confirmed that the thermal stability of both live and inactivated NDV vaccines could be improved by increasing the negative surface charge of HN protein.
Improved thermal stability of IAV vaccine by increasing the negative surface charge of HA protein
A total of 26,827 attachment glycoprotein sequences from 10 enveloped viruses were analyzed for their theoretical charges at pH 7.4. The percentage distribution of these protein sequences from each virus according to their charge was analyzed. As shown in Fig 7A, the highest negative and positive charge values of these glycoproteins were ˗22 and +6, respectively. Among these viruses, the widest charge range was observed for the HA of H5N1 IAV virus, while the HN of mumps virus, E of Zika virus, and GP of Ebola virus showed the narrowest charge range. Most of the attachment glycoproteins were negatively charged, and the charges of proteins varied greatly between enveloped viruses, even between isolates of the same virus. It was indicated that the thermostability of other enveloped viruses could also be improved by surface charge engineering.
Then we tested whether the thermostability of H1N1 IAV strain PR8-E could be improved using this method. The HA protein sequence of PR8-E was compared with those of strains SC18 and FAV09, representing relatively high and low negative charges, respectively. In total, 39 charge-associated amino acid substitutions were identified in the HA protein (Fig 7B), and 10 of them were utilized to construct two IAV mutants rPR8-HA-N5 and rPR8-HA-P5 bearing HA proteins with different charges (Fig 7C). The thermostabilities of rIAVs were assessed. As expected, the viral thermostabilities of rPR8-HA-N5 and rPR8-HA-P5 were considerably changed, in the order of rPR8-HA-N5 > rPR8-E > rPR8-HA-P5 (Fig 7D). The structures of the HA proteins from the IAV mutants were obtained by molecular modeling. Similar to the results from NDV, the IAV bearing HA with a high negative surface charge also exhibited high viral thermostability (Fig 7E–7G). In addition, two IAV mutants showed similar growth kinetics and pathogenicity compared with the parental rPR8-E virus (S9 Fig). These findings indicated that the thermostability of IAV could be regulated by surface charge engineering.
The loss of potency of rPR8-HA-N5, as an inactivated vaccine, during storage was assessed. The inactivated vaccine rPR8-HA-N5 was stored at 37°C for varying time periods, and the subsequent HA activities were determined. The mean time taken to achieve a 90% decrease in the HA activity of rPR8-HA-N5 vaccine was 126.3 days, and this was 4.7-fold higher than that of rPR8-E vaccine (Fig 7H). The immunogenicity of the heat-treated inactivated vaccines was then verified in animals. Inactivated vaccines were incubated at 37°C for 30 and 60 days, and groups of mice were then immunized via the im route. As shown in Fig 7I and 7J, before heat-treatment, the mean HI antibody titers in group rPR8-HA-N5 and rPR8-E were 6.7 and 5.3 log2, respectively. After storage for 30 days, the HI titer in the rPR8-E group decreased to 2.0 log2, and rPR8-E vaccine could provide only 20% protection against the lethal challenge. However, rPR8-HA-N5 vaccine could still provide complete protection after storage at 37°C for 60 days. Therefore, the thermal stability of IAV inactivated vaccine could also be improved by increasing the negative surface charge of HA protein.
Discussion
We report here a novel mechanism for the thermostability of NDV and propose its application in the rational design of thermostable NDV and IAV vaccines. The negative surface charge of HN protein positively regulated the thermostability of NDV through preventing the aggregation of HN protein. By genetically engineering charge-associated amino acid mutations onto the surface of the attachment glycoprotein of an enveloped virus vaccine strain, the thermal stability of both the live and inactivated vaccines could be greatly improved. Thus, we propose a model specifying that the surface charge of HN protein is “the key determinant” for viral thermostability (Fig 8).
The first step of NDV infection is the binding of HN protein to a sialic acid receptor on host cells. When a thermolabile virion was subjected to environmental heat, HN proteins with low negative surface charge tended to aggregate, and detach from viral particles. Then, the naked viral particles could not bind to cells and viral infection would not occur. However, when the thermostable virion was subjected to heat, HN proteins with high negative surface charge did not aggregate, and remained evenly distributed on the viral particles. This allowed for the initiation of infection and a complete cycle of viral replication. The findings that viral thermostability is regulated by the surface charge of HN protein and the potential application of this knowledge in the rational design of thermostable vaccines, highlights the importance of protein charge in the biological characterization of enveloped viruses.
The structural stability of the virion surface is of great importance in viral thermostability. For non-enveloped viruses, the outermost covering of viral particles is the capsid, which is composed of proteins. The thermostability of non-enveloped viruses is affected mainly by capsid proteins. It has been reported that the thermostability of foot-and-mouth disease virus, a typical non-enveloped virus, could be improved by replacing the amino acids located near the capsid inter-subunit interface, to establish new disulfide or electrostatic interactions between subunits, which protects the capsid against thermal dissociation into pentameric subunits [16]. Unlike non-enveloped viruses, the outermost covering of enveloped viruses comprises phospholipids and proteins, which surround the capsid. Several studies had shown that the attachment glycoproteins exposed on the surface of viral particles play an important role in viral thermostability [21,41,42]. Here, we further confirmed that the negative surface charge of HN protein affected NDV thermostability through regulating the structural stability of the virion surface.
Although the thermostability of enveloped viruses has been studied extensively, the mechanism for viral thermostability remained poorly understood. In cryo-electron microscopy studies, when incubated at 40°C, Zika virus was structurally stable and remained as a smooth-surface particle [42]. By contrast, Dengue virus, another Flavivirus with less thermostability than Zika virus, underwent notable structural changes from smooth to bumpy-surfaced particles at an elevated temperature of 37°C [43]. However, these conformational changes of Dengue virus particles did not affect viral infectivity [44]. Using reverse genetic technology, only a few amino acid mutations in the attachment glycoprotein that affected viral thermostability were identified [41]. In Zika virus, a single amino acid mutation T267Q within the helix αB region of E protein greatly decreased viral thermostability, indicating that the hydrophobic interactions between M protein and helix αB of the protein are critical for Flavivirus thermostability [45]. In IAV, the recombinant virus harboring mutation E47K in the stalk region of the HA2 subunit, displayed increased resistance to high temperature treatment, suggesting that the inter-monomer salt bridge between E21 in HA1 and K47 stabilizes the trimer structure of HA [46]. Our previous study demonstrated that HN protein was the crucial determinant of viral thermostability by exchanging NDV genes between thermostable TS09-C and thermolabile LaSota strains [21]. However, we were unable to identify the region in HN that critically affected viral thermostability through fragment exchange. This implied that viral thermostability was not dependent on a single amino acid; rather, it might be determined by a combination of amino acids located at several regions in HN protein. Inspired by the contribution of electrostatics to protein behavior [47,48], we found that the thermostability of two typical enveloped viruses, NDV and IAV, could be altered by regulating the negative surface charge of attachment glycoprotein.
Modulating the surface charge had been proven to reduce aggregation and improve the stability of proteins, such as GFP and a single chain variable fragment antibody [49,50]. Here, we successfully improved the stability of a viral attachment glycoprotein HN by increasing its negative surface charge via preventing temperature-induced aggregation. It was proposed that the long-range repulsive electrostatic forces originating from the protein’s surface charge were mainly responsible for the temperature-induced aggregation [51]. The stronger the repulsive electrostatic forces of a protein, the higher the temperature required for aggregation. These forces could be manipulated by changing the protein amino acid sequence or by changing the pH or the concentration of solute molecules and thus the surface charge [52,53]. The role of the protein surface charge was supported by colloid models. A common strategy to stabilize proteins is simply to adjust the solution pH away from the protein’s isoelectric point, which confers a net charge on the protein [54]. The value of Tm-CD was slightly higher than that of Tm-SZ, and similar to that of Tm-NA, indicating that the aggregation occurred earlier than the state transition of the protein during heat-treatment. Therefore, it was proposed that the heat-treatment induced the aggregation of HN protein, which could be influenced by the repulsive electrostatic forces derived from the protein surface charge. Then, the aggregation of protein led to the burial of most protein active sites and subsequent inactivation of the protein.
Virus in suspension also tends to aggregate near to, or at, the isoelectric point, where repulsive electrostatic forces are weakest [55,56]. The pH, the type of salts, and the salt concentration of the solution could affect the charge, repulsive forces, and subsequent aggregation of the virus [57,58]. Viral aggregates had been used to explain the nonlinear nature of virus inactivation in the environment and resistance to disinfectants [59,60]. Here, we did not detect the aggregation of heat-treated thermostable and thermolabile rNDVs (Figs 3C and S4). The charges of HN proteins distributed intensively and evenly on the viral surface, differed greatly between thermostable and thermolabile NDVs, which affected the temperature-induced aggregation and detachment of adjacent HN proteins and subsequent viral infectivity (Fig 8).
Most vaccines are sensitive to heat and are thereby strictly dependent on a cold chain to maintain their quality. This presents a huge burden for developing regions lacking reliable and extensive refrigeration infrastructure. Such regions are therefore particularly vulnerable to vaccine failure, which further increases the disease burden [61]. Thermostable vaccines with reduced dependence on a cold chain could greatly extend the global coverage of vaccines by decreasing costs, ensuring potency, and reducing waste. Here, we engineered charge-associated amino acid mutations into vaccine strains by reverse genetics to increase the negative surface charge of attachment glycoprotein which, in turn, enhanced the thermal stability of both NDV and IAV vaccines. High level antibody responses could be induced in animals immunized with the live and inactivated liquid vaccines after storage at 37°C for 10 and 60 days, respectively. These thermostable vaccines could be guaranteed for use without any access to refrigeration for at least 10 days, under a wide range of ambient temperatures, such as those experienced in tropical regions without a reliable cold chain. During the transportation and storage of vaccines, deviation from the ideal storage temperature is inevitable [62], and cases of cold chain breakdown occasionally occur. Most reconstituted vaccines must be used within a few hours because of their rapid loss of potency [63]. Our results indicated that the thermostable vaccines could be provided in a liquid formulation, without the need for freeze-drying and reconstitution before injection, and survived extended exposure times even under a wide range of ambient temperatures. In addition, compared with the control vaccine, the genetically engineered vaccines displayed slightly increased immunogenicity (Figs 6E, 6H, and 7I). A possible explanation for this was that the integrity of the virion surface of the engineered virus was superior to that of the control virus.
Unlike the previously described methods, our approach of surface charge engineering could be used to quantitatively regulate the thermal stability of vaccines by changing the negative surface charge of attachment glycoprotein. The increase in the level of viral thermostability was determined by the value-added in the negative surface charge of attachment glycoprotein. Our approach concentrated only on the surface charge of attachment glycoprotein, and the charge-associated amino acid mutations used to change the protein charge could be obtained simply from sequence alignment. The thermostable vaccines could be produced simply by propagating the vaccine strains, without additional procedures, such as the addition of the stabilized excipients or the induction of vaccine bio-mineralization [13], thus allowing pharmaceutical companies to manufacture thermostable vaccines simply and economically. Importantly, the wide charge range of attachment glycoprotein from many enveloped viruses was observed, and the sequences and structures of these attachment glycoproteins have been resolved. Therefore, these viruses could readily be genetically modified, and analogous thermostability improvements achieved by surface charge engineering might be applied to more viral vaccines. In addition to live and inactivated vaccines, other types of vaccines, such as virus-like particles and subunit vaccines, might also be genetically modified to increase the protein negative surface charge and confer improved thermal stability to vaccine products.
In summary, our study of two important enveloped viruses revealed a previously unknown surface-charge-mediated link between HN protein and NDV thermostability, and proposed its application in the rational design of thermostable NDV and IAV vaccines. These findings might reshape the current understanding of the regulatory function and mechanism of the surface charge of viral proteins. The discovery of this surface-charge-mediated mechanism for viral thermostability will improve our ability to predict the pandemic potential of circulating viruses by monitoring the charge of attachment glycoprotein. It may also provide a novel strategy for the rational design of thermostable vaccines to assist in the execution and expansion of global immunization programs, especially for developing and less-developed countries.
Supporting information
Acknowledgments
The authors thank Patti Miller and Zhenyu Chen for helpful discussion and critical reading of the manuscript.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This research was supported by the National Natural Science Foundation of China (grant 31873018 (GW) and 31670157 (HS)), the China Agriculture Research System (grant CARS-41-G13) (HS) and the Special Fund for innovative technology of Hubei province (grant 2019CFA071) (GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Alexander DJSD. Newcastle Disease, Other Avian Paramyxoviruses, and Pneumovirus Infections. In: Saif YM, Glisson JR, McDougald LR, Nolan LK, Swayne DE, editors. Diseases of Poultry. 12th ed. Ames, IA, USA: Blackwell Publishing; 2008. [Google Scholar]
- 2.Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–9. doi: 10.1016/S0140-6736(16)00562-6 ; PubMed Central PMCID: PMC5444521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333–40. doi: 10.1001/jama.292.11.1333 . [DOI] [PubMed] [Google Scholar]
- 4.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. doi: 10.1056/NEJMoa2001017 ; PubMed Central PMCID: PMC7092803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chen X, Fernando GJ, Crichton ML, Flaim C, Yukiko SR, Fairmaid EJ, et al. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Control Release. 2011;152(3):349–55. Epub 2011/03/05. S0168-3659(11)00111-8 [pii] doi: 10.1016/j.jconrel.2011.02.026 . [DOI] [PubMed] [Google Scholar]
- 6.Das P. Revolutionary vaccine technology breaks the cold chain. Lancet Infect Dis. 2004;4(12):719. Epub 2004/12/14. S1473-3099(04)01222-8 [pii]. doi: 10.1016/s1473-3099(04)01222-8 . [DOI] [PubMed] [Google Scholar]
- 7.Milhomme P. Cold chain study: danger of freezing vaccines. Can Commun Dis Rep. 1993;19(5):33–8. Epub 1993/03/15. . [PubMed] [Google Scholar]
- 8.Nelson CM, Wibisono H, Purwanto H, Mansyur I, Moniaga V, Widjaya A. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull World Health Organ. 2004;82(2):99–105. Epub 2004/03/26. S0042-96862004000200006 [pii]. ; PubMed Central PMCID: PMC2585906. [PMC free article] [PubMed] [Google Scholar]
- 9.Setia S, Mainzer H, Washington ML, Coil G, Snyder R, Weniger BG. Frequency and causes of vaccine wastage. Vaccine. 2002;20(7–8):1148–56. Epub 2002/01/23. S0264410X01004339 [pii]. doi: 10.1016/s0264-410x(01)00433-9 . [DOI] [PubMed] [Google Scholar]
- 10.Schlehuber LD, McFadyen IJ, Shu Y, Carignan J, Duprex WP, Forsyth WR, et al. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay. Vaccine. 2011;29(31):5031–9. doi: 10.1016/j.vaccine.2011.04.079 . [DOI] [PubMed] [Google Scholar]
- 11.Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines. 2009;8(5):547–57. Epub 2009/04/29. doi: 10.1586/erv.09.20 . [DOI] [PubMed] [Google Scholar]
- 12.Naik SP, Zade JK, Sabale RN, Pisal SS, Menon R, Bankar SG, et al. Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL(R)). Vaccine. 2017;35(22):2962–9. Epub 2017/04/25. S0264-410X(17)30499-1 [pii] doi: 10.1016/j.vaccine.2017.04.025 . [DOI] [PubMed] [Google Scholar]
- 13.Wang G, Cao RY, Chen R, Mo L, Han JF, Wang X, et al. Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions. Proc Natl Acad Sci U S A. 2013;110(19):7619–24. Epub 2013/04/17. 1300233110 [pii] doi: 10.1073/pnas.1300233110 ; PubMed Central PMCID: PMC3651461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Back JW, Langedijk JP. Structure-based design for high-hanging vaccine fruits. Adv Immunol. 2012;114:33–50. Epub 2012/03/28. doi: 10.1016/B978-0-12-396548-6.00002-0 [pii] . [DOI] [PubMed] [Google Scholar]
- 15.Delany I, Rappuoli R, De Gregorio E. Vaccines for the 21st century. EMBO Mol Med. 2014;6(6):708–20. Epub 2014/05/08. emmm.201403876 [pii] doi: 10.1002/emmm.201403876 ; PubMed Central PMCID: PMC4203350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Mateo R, Luna E, Rincon V, Mateu MG. Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. J Virol. 2008;82(24):12232–40. Epub 2008/10/03. JVI.01553-08 [pii] doi: 10.1128/JVI.01553-08 ; PubMed Central PMCID: PMC2593342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GB, Yang Y, et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science. 2013;342(6158):592–8. Epub 2013/11/02. 342/6158/592 [pii] doi: 10.1126/science.1243283 ; PubMed Central PMCID: PMC4461862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lomniczi B. Thermostability of Newcastle disease virus strains of different virulence. Arch Virol. 1975;47(3):249–55. Epub 1975/01/01. doi: 10.1007/BF01317812 . [DOI] [PubMed] [Google Scholar]
- 19.Wen G, Shang Y, Guo J, Chen C, Shao H, Luo Q, et al. Complete genome sequence and molecular characterization of thermostable Newcastle disease virus strain TS09-C. Virus Genes. 2013;46(3):542–5. Epub 2013/01/09. doi: 10.1007/s11262-012-0871-1 . [DOI] [PubMed] [Google Scholar]
- 20.Nguyen Ba V. [Evaluation of the thermo-tolerability of the lyophilized V4 vaccine against Newcastle disease]. Rev Elev Med Vet Pays Trop. 1992;45(3–4):235–40. Epub 1992/01/01. . [PubMed] [Google Scholar]
- 21.Wen G, Hu X, Zhao K, Wang H, Zhang Z, Zhang T, et al. Molecular basis for the thermostability of Newcastle disease virus. Sci Rep. 2016;6:22492. Epub 2016/03/05. srep22492 [pii] doi: 10.1038/srep22492 ; PubMed Central PMCID: PMC4776148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Smith EC, Popa A, Chang A, Masante C, Dutch RE. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 2009;276(24):7217–27. Epub 2009/11/03. EJB7401 [pii] doi: 10.1111/j.1742-4658.2009.07401.x ; PubMed Central PMCID: PMC2795005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000;7(11):1068–74. Epub 2000/11/04. doi: 10.1038/81002 . [DOI] [PubMed] [Google Scholar]
- 24.Yuan P, Swanson KA, Leser GP, Paterson RG, Lamb RA, Jardetzky TS. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A. 2011;108(36):14920–5. Epub 2011/08/30. 1111691108 [pii] doi: 10.1073/pnas.1111691108 ; PubMed Central PMCID: PMC3169104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pace CN, Grimsley GR, Scholtz JM. Protein ionizable groups: pK values and their contribution to protein stability and solubility. J Biol Chem. 2009;284(20):13285–9. doi: 10.1074/jbc.R800080200 ; PubMed Central PMCID: PMC2679426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zhou HX, Pang X. Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation. Chem Rev. 2018;118(4):1691–741. doi: 10.1021/acs.chemrev.7b00305 ; PubMed Central PMCID: PMC5831536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cashdollar JL, Dahling DR. Evaluation of a method to re-use electropositive cartridge filters for concentrating viruses from tap and river water. J Virol Methods. 2006;132(1–2):13–7. doi: 10.1016/j.jviromet.2005.08.016 . [DOI] [PubMed] [Google Scholar]
- 28.Brorson K, Shen H, Lute S, Perez JS, Frey DD. Characterization and purification of bacteriophages using chromatofocusing. J Chromatogr A. 2008;1207(1–2):110–21. doi: 10.1016/j.chroma.2008.08.037 . [DOI] [PubMed] [Google Scholar]
- 29.Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J Virol. 2008;82(11):5650–2. doi: 10.1128/JVI.00325-08 ; PubMed Central PMCID: PMC2395183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Paek MR, Lee YJ, Yoon H, Kang HM, Kim MC, Choi JG, et al. Survival rate of H5N1 highly pathogenic avian influenza viruses at different temperatures. Poult Sci. 2010;89(8):1647–50. doi: 10.3382/ps.2010-00800 . [DOI] [PubMed] [Google Scholar]
- 31.Pirtle EC, Beran GW. Virus survival in the environment. Rev Sci Tech. 1991;10(3):733–48. doi: 10.20506/rst.10.3.570 . [DOI] [PubMed] [Google Scholar]
- 32.Stallknecht DE, Shane SM, Kearney MT, Zwank PJ. Persistence of avian influenza viruses in water. Avian Dis. 1990;34(2):406–11. . [PubMed] [Google Scholar]
- 33.Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology. 1978;84(2):268–78. doi: 10.1016/0042-6822(78)90247-7 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Alexander DJ. Newcastle disease virus and other avian paramyxoviruses. In: Swayne D, Glisson JR, Jackwood MW, Pearson JE, Reed WM. A laboratory manual for the isolation and identification of avian pathogens. 4th ed Kennett Square, PA: American Association of Avian Pathologists. 1998. [Google Scholar]
- 35.Wen G, Chen C, Guo J, Zhang Z, Shang Y, Shao H, et al. Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene. J Gen Virol. 2015;96(Pt 6):1219–28. doi: 10.1099/vir.0.000067 . [DOI] [PubMed] [Google Scholar]
- 36.Wu R, Chen Q, Zheng L, Chen J, Sui Z, Guan Y, et al. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza. Arch Virol. 2009;154(8):1203–10. doi: 10.1007/s00705-009-0425-6 . [DOI] [PubMed] [Google Scholar]
- 37.Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 2003;31(13):3381–5. doi: 10.1093/nar/gkg520 ; PubMed Central PMCID: PMC168927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A. 2001;98(18):10037–41. doi: 10.1073/pnas.181342398 ; PubMed Central PMCID: PMC56910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Srinivasakumar N, Ogra PL, Flanagan TD. Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol. 1991;65(8):4063–9. doi: 10.1128/JVI.65.8.4063-4069.1991 ; PubMed Central PMCID: PMC248838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Takimoto T, Taylor GL, Crennell SJ, Scroggs RA, Portner A. Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology. 2000;270(1):208–14. doi: 10.1006/viro.2000.0263 . [DOI] [PubMed] [Google Scholar]
- 41.Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486(7403):420–8. doi: 10.1038/nature10831 ; PubMed Central PMCID: PMC3388103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kostyuchenko VA, Lim EX, Zhang S, Fibriansah G, Ng TS, Ooi JS, et al. Structure of the thermally stable Zika virus. Nature. 2016;533(7603):425–8. doi: 10.1038/nature17994 . [DOI] [PubMed] [Google Scholar]
- 43.Zhang X, Sheng J, Plevka P, Kuhn RJ, Diamond MS, Rossmann MG. Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A. 2013;110(17):6795–9. doi: 10.1073/pnas.1304300110 ; PubMed Central PMCID: PMC3637732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Fibriansah G, Ng TS, Kostyuchenko VA, Lee J, Lee S, Wang J, et al. Structural changes in dengue virus when exposed to a temperature of 37 degrees C. J Virol. 2013;87(13):7585–92. doi: 10.1128/JVI.00757-13 ; PubMed Central PMCID: PMC3700303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Xie DY, Liu ZY, Nian QG, Zhu L, Wang N, Deng YQ, et al. A single residue in the alphaB helix of the E protein is critical for Zika virus thermostability. Emerg Microbes Infect. 2018;7(1):5. doi: 10.1038/s41426-017-0006-9 ; PubMed Central PMCID: PMC5837149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cotter CR, Jin H, Chen Z. A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS Pathog. 2014;10(1):e1003831. doi: 10.1371/journal.ppat.1003831 ; PubMed Central PMCID: PMC3879363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Curtis RA, Prausnitz JM, Blanch HW. Protein-protein and protein-salt interactions in aqueous protein solutions containing concentrated electrolytes. Biotechnol Bioeng. 1998;57(1):11–21. doi: . [DOI] [PubMed] [Google Scholar]
- 48.Goldenberg NM, Steinberg BE. Surface charge: a key determinant of protein localization and function. Cancer Res. 2010;70(4):1277–80. doi: 10.1158/0008-5472.CAN-09-2905 . [DOI] [PubMed] [Google Scholar]
- 49.Lawrence MS, Phillips KJ, Liu DR. Supercharging proteins can impart unusual resilience. J Am Chem Soc. 2007;129(33):10110–2. doi: 10.1021/ja071641y ; PubMed Central PMCID: PMC2820565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Miklos AE, Kluwe C, Der BS, Pai S, Sircar A, Hughes RA, et al. Structure-based design of supercharged, highly thermoresistant antibodies. Chem Biol. 2012;19(4):449–55. doi: 10.1016/j.chembiol.2012.01.018 ; PubMed Central PMCID: PMC5583727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Laber JR, Dear BJ, Martins ML, Jackson DE, DiVenere A, Gollihar JD, et al. Charge Shielding Prevents Aggregation of Supercharged GFP Variants at High Protein Concentration. Mol Pharm. 2017;14(10):3269–80. doi: 10.1021/acs.molpharmaceut.7b00322 ; PubMed Central PMCID: PMC5624851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kanai S, Liu J, Patapoff TW, Shire SJ. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci. 2008;97(10):4219–27. doi: 10.1002/jps.21322 . [DOI] [PubMed] [Google Scholar]
- 53.Liu J, Nguyen MD, Andya JD, Shire SJ. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. J Pharm Sci. 2005;94(9):1928–40. doi: 10.1002/jps.20347 . [DOI] [PubMed] [Google Scholar]
- 54.Cleland JL, Powell MF, Shire SJ. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst. 1993;10(4):307–77. . [PubMed] [Google Scholar]
- 55.Heffron J, Mayer BK. Virus Isoelectric Point Estimation: Theories and Methods. Appl Environ Microbiol. 2021;87(3). doi: 10.1128/AEM.02319-20 ; PubMed Central PMCID: PMC7848896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Michen B, Graule T. Isoelectric points of viruses. J Appl Microbiol. 2010;109(2):388–97. doi: 10.1111/j.1365-2672.2010.04663.x . [DOI] [PubMed] [Google Scholar]
- 57.Mertens BS, Velev OD. Characterization and control of surfactant-mediated Norovirus interactions. Soft Matter. 2015;11(44):8621–31. doi: 10.1039/c5sm01778e ; PubMed Central PMCID: PMC4666303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Samandoulgou I, Fliss I, Jean J. Zeta Potential and Aggregation of Virus-Like Particle of Human Norovirus and Feline Calicivirus Under Different Physicochemical Conditions. Food Environ Virol. 2015;7(3):249–60. doi: 10.1007/s12560-015-9198-0 . [DOI] [PubMed] [Google Scholar]
- 59.Gerba CP, Betancourt WQ. Viral Aggregation: Impact on Virus Behavior in the Environment. Environ Sci Technol. 2017;51(13):7318–25. doi: 10.1021/acs.est.6b05835 . [DOI] [PubMed] [Google Scholar]
- 60.Young DC, Sharp DG. Poliovirus aggregates and their survival in water. Appl Environ Microbiol. 1977;33(1):168–77. doi: 10.1128/aem.33.1.168-177.1977 ; PubMed Central PMCID: PMC170618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Clemens J, Holmgren J, Kaufmann SH, Mantovani A. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress. Nat Immunol. 2010;11(12):1069–72. doi: 10.1038/ni1210-1069 . [DOI] [PubMed] [Google Scholar]
- 62.Braun LJ, Jezek J, Peterson S, Tyagi A, Perkins S, Sylvester D, et al. Characterization of a thermostable hepatitis B vaccine formulation. Vaccine. 2009;27(34):4609–14. doi: 10.1016/j.vaccine.2009.05.069 . [DOI] [PubMed] [Google Scholar]
- 63.Zhang J, Pritchard E, Hu X, Valentin T, Panilaitis B, Omenetto FG, et al. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A. 2012;109(30):11981–6. doi: 10.1073/pnas.1206210109 ; PubMed Central PMCID: PMC3409735. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the manuscript and its Supporting Information files.